fbpx

C&D Technologies

Robbins Umeda LLP Announces an Investigation of C&D Technologies, Inc.

Robbins Umeda LLP, a shareholder rights litigation firm, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the board of directors of C&D Technologies, Inc. (OTC: CHHP) in connection with their efforts to sell the company to an affiliate of Angelo, Gordon & Co. 

On October 3, 2011, C&D announced that it had entered into a definitive merger agreement pursuant to which an affiliate of Angelo, Gordon & Co. will acquire all outstanding shares of the company in an all cash transaction.  According to the terms of the deal, shareholders will receive $9.75 for each share of C&D they own.  The transaction is expected to close in the fourth quarter of 2011.

Robbins Umeda LLP’s investigation focuses on whether C&D’s board is undertaking a fair process to obtain maximum value and adequately compensate shareholders in light of the company’s improving financial results.  On September 7, 2011, the company announced second quarter 2011 revenue of $94.6 million, up 13% compared to the $83.8 million reported in the second quarter of 2010. 

Robbins Umeda is also investigating whether self-dealing and other employment guarantees played a part in the decision by the board to enter into the merger agreement.  Upon closure, the officers of C&D will continue to serve as the officers of the surviving corporation.  Furthermore, C&D revealed that shareholders affiliated with Angelo, Gordon & Co., who hold approximately 65% of the outstanding shares of C&D’s common stock, have executed a written consent to approve the transaction, providing the required shareholder approval for this transaction.  Therefore, no further action by other stockholders of C&D is required to approve the transaction.

If you own stock in C&D and would like more information about your shareholder rights, please complete the form below and we will contact you directly.  We also welcome you to call us at 800-350-6003.

Send us a message for more information.